Aurora Cannabis Inc.

ACB

CA05156X8504

Pharmaceuticals

Market Closed - Toronto S.E. Other stock markets 16:00:00 2026-02-13 EST			5-day change	1st Jan Change
4.870 ^CAD	+6.10%		+2.10%	-15.60%

02-11	Aurora Advances Global Medical Growth Strategy with Portfolio Expansion in Australia & New Zealand	CI
02-11	Aurora Brief: Advancing Global Medical Growth Strategy With Portfolio Expansion In Australia & New Zealand	MT

Aurora Cannabis announces filing of prospectus supplement for at-the-market offering program

Published on 02/04/2026 at 09:32 am EST

Reuters

Latest news about Aurora Cannabis Inc.

02-11	Aurora Advances Global Medical Growth Strategy with Portfolio Expansion in Australia & New Zealand	CI
02-11	Aurora Brief: Advancing Global Medical Growth Strategy With Portfolio Expansion In Australia & New Zealand	MT
02-04	Toronto Stocks Slide; ATS Shares Rise on 3Q Beats, Bookings Rebound	DJ
02-04	Aurora Cannabis Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
02-04	Aurora Cannabis Inc., Q3 2026 Earnings Call, Feb 04, 2026
02-04	Aurora Cannabis announces filing of prospectus supplement for at-the-market offering program	RE
02-04	Aurora Cannabis Up In US Premarket On Q3 Revenue Beat and Bullish FY26 Expectations	MT
02-04	Earnings Flash (ACB) Aurora Cannabis Inc. Reports Q3 Adjusted net income was $7.2 Million	MT
02-04	Aurora Cannabis Brief: Says Maintains Strong Balance Sheet with $154.4M of Cash and Short-Term Investments, and a Debt-Free Cannabis Business	MT
02-04	Aurora Cannabis Brief: Expands Q3 YoY Total Net Revenue by 7% to $94.2 Million	MT
02-04	Aurora Cannabis Inc. to Seek M&A	CI
02-04	North American Morning Briefing : Software Jitters Rattle Global Markets -2-	DJ
02-03	Aurora Cannabis Launches New European Websites	MT
01-20	Aurora Cannabis Secures EU Community Plant Rights for Two Cannabis Varieties	MT
01-20	Aurora Brief: Says Secured EU Community Plant Variety Rights for Two Proprietary Cannabis Varieties	MT

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Companyâ€™s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally, and the propagation of vegetables and ornamental plants in North America. Its segments include Canadian Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. It also has a controlling interest in Bevo Farms Ltd., North America's supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, TerraFarma Inc., Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.

Employees

1,073

Sector

Pharmaceuticals

Calendar

06-17 - Q4 2026 Earnings Release (Projected)

More about the company